| Mar'12 | Dec'11 | Sep'11 | Jun'11 | Mar'11 | Dec'10 |
|---|---|---|---|---|---|
Cash | |||||
-62 | - | - | - | -71 | - |
Cash | |||||
- | -62 | -71 | -71 | - | -71 |
Accounts receivable | |||||
0 | 0 | 0 | 0 | 0 | 0 |
Total current assets | |||||
-62 | -62 | -71 | -71 | -71 | -71 |
Investments - (Note 10) | |||||
25 | 25 | 25 | 25 | 25 | 25 |
Note Receivable2 from ESOP Trust - (Note 11) | |||||
18,863 | 18,863 | 18,863 | 18,863 | 18,863 | 18,863 |
Total other assets | |||||
18,888 | 18,888 | 18,888 | 18,888 | 18,888 | 18,888 |
PROPERTY AND EQUIPMENT, net of accumulated depreciation | |||||
0 | 0 | 0 | 0 | 0 | 0 |
Brands; Rights; Services and Contracts | |||||
24 | 24 | 27 | 27 | 27 | 27 |
Goodwill | |||||
3 | 3 | 4 | 4 | 4 | 4 |
Total intangible assets | |||||
28 | - | - | - | 31 | - |
Total intangible assets | |||||
- | 28 | 31 | 31 | - | 31 |
Total assets | |||||
18,854 | 18,854 | 18,848 | 18,848 | 18,848 | 18,848 |
Accounts payable | |||||
14 | 11 | 9 | 1 | 1 | 1 |
Advances from stockholder | |||||
8 | 8 | 8 | 8 | 8 | 8 |
Total current liabilities | |||||
23 | 20 | 18 | 9 | 9 | 9 |
Credit card cash advances - (Note 4) | |||||
38 | 38 | 38 | 38 | 38 | 38 |
Interest Payable - Credit card advances (Note 4) | |||||
57 | 57 | 52 | 52 | 52 | 52 |
Loans from stockholders - (Note 6) | |||||
26 | 26 | 26 | 26 | 26 | 26 |
Interest Payable - Stockholders' Loans - (Note 6) | |||||
9 | 9 | - | - | 8 | 8 |
Interest Payable - Stockholders' Loans - (Note 6) | |||||
- | - | 8 | 8 | - | - |
Series 2010A; 7% percent; $1,000 par value; convertible; callable; 144A; First Mortgage Bonds due 2020 - (Note 13) | |||||
30,000 | 30,000 | 30,000 | 30,000 | 30,000 | 30,000 |
Discount on Series 2010A; 144A Bond Issuance - (Note 14) | |||||
11,136 | 11,136 | 11,136 | 11,136 | 11,136 | 11,136 |
Total long term liabilities | |||||
18,995 | 18,995 | 18,989 | 18,989 | 18,989 | 18,989 |
Total liabilities | |||||
19,019 | 19,016 | 19,008 | 18,999 | 18,999 | 18,999 |
COMMITMENT - (Note 9) | |||||
0 | 0 | - | 0 | 0 | 0 |
Preferred stock, 7 ¼ percent; $1.00 stated value, 5,000,000 shares authorized; 1,000,000 shares issued and outstanding - (Note 8) | |||||
1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
Common stock, no par value, 100,000,000 shares authorized; 48,022,500 shares issued and outstanding ($.01 stated value) | |||||
480 | 480 | 480 | 480 | 480 | 480 |
Additional paid-in capital | |||||
48,818 | 48,818 | 48,818 | 48,817 | 48,816 | 48,816 |
Note receivable1 from ESOP - (Note 7) | |||||
50,099 | 50,099 | 50,099 | 50,099 | 50,099 | 50,099 |
Deficit accumulated during the development stage | |||||
364 | 360 | 357 | 348 | 347 | 347 |
Total stockholders' deficit | |||||
-164 | -161 | -159 | -150 | -150 | -150 |
Total liabilities and stockholders' deficit | |||||
-18,854 | -18,854 | 18,848 | -18,848 | -18,848 | -18,848 |